FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis

Journal of Molecular Cell Biology

Volumn 5, Issue 5, 2013, Pages 294-307

  Neguembor, Maria Victoria ^a,b   Xynos, Alexandros ^a   Onorati, Maria Cristina ^c   Caccia, Roberta ^a   Bortolanza, Sergia ^a   Godio, Cristina ^a   Pistoni, Mariaelena ^a   Corona, Davide F ^c   Schotta, Gunnar ^d   Gabellini, Davide ^a  

^a DULBECCO TELETHON INSTITUTE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

chromatin; copy number variation; D4Z4; H4K20; KMT5B; muscle differentiation; SUV4 20H1

Indexed keywords

FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY REGION GENE 1; HISTONE METHYLTRANSFERASE; SUV4 20H1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONSTITUTIVE HETEROCHROMATIN; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVITY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; UPREGULATION;

CHROMATIN; COPY NUMBER VARIATION; D4Z4; H4K20; KMT5B; MUSCLE DIFFERENTIATION; SUV4-20H1;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL NUCLEUS; DROSOPHILA MELANOGASTER; EVOLUTION, MOLECULAR; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE CELLS; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, ANIMAL; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PHENOTYPE; PROTEIN BINDING; PROTEINS;

EID: 84885342118     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjt018     Document Type: Article

References (52)

1. Barro, M., Carnac, G., Flavier, S., et al. (2005). Myoblasts from affected and nonaffected FSHD muscles exhibit morphological differentiation defects. J. Cell. Mol. Med. 14, 275-289.
2. Bavner, A., Matthews, J., Sanyal, S., et al. (2005). EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. Nucleic Acids Res. 33, 3561-3569.
3. Benetti, R., Gonzalo, S., Jaco, I., et al. (2007). Suv4-20h deficiency results in telomereelongationand derepressionof telomere recombination. J. Cell Biol. 178, 925-936.
4. Biron, V.L., McManus, K.J., Hu, N., et al. (2004). Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development. Dev. Biol. 276, 337-351.
5. Burgio, G., La Rocca, G., Sala, A., et al. (2008). Genetic identification of a network of factors that functionally interact with the nucleosome remodeling ATPase ISWI. PLoS Genet. 4, e1000089.
6. Cabianca, D.S., and Gabellini, D. (2010). The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy. J. Cell Biol. 191, 1049-1060.
7. Cabianca, D.S., Casa, V., Bodega, B., et al. (2012). A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch inFSHDmuscular dystrophy. Cell 149, 819-831.
8. Celegato, B., Capitanio, D., Pescatori, M., et al. (2006). Parallel protein and transcript profiles of FSHD patient muscles correlate to theD4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6, 5303-5321.
9. Dubowitz,V. (1985). Muscle Biopsy:APracticalApproach. London: Bailliere Tindall.
10. Fitzsimons, R.B., Gurwin, E.B., and Bird, A.C. (1987). Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 110(Pt 3), 631-648.
11. Gabellini, D., Green, M.R., and Tupler, R. (2002). Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110, 339-348.
12. Gabellini, D., D'Antona, G., Moggio, M., et al. (2006). Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439, 973-977.
13. Gonzalo, S., Garcia-Cao, M., Fraga, M.F., et al. (2005). Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol. 7, 420-428.
14. Griggs, R.C., Tawil, R., McDermott, M., et al. (1995). Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group. Muscle Nerve Suppl. 2, S50-S55.
15. Hanel,M.L.,Wuebbles, R.D.,andJones,P.L. (2009).Musculardystrophy candidate gene FRG1 is critical for muscle development. Dev. Dyn. 238, 1502-1512.
16. Hanel, M.L., Sun, C.Y., Jones, T.I., et al. (2011). Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein. Differentiation 81, 107-118.
17. Hobbs, R.M., Fagoonee, S., Papa, A., et al. (2012). Functional antagonism between Sall4 and Plzf defines germline progenitors. Cell Stem Cell 10, 284-298.
18. Hsu, Y.D., Kao, M.C., Shyu, W.C., et al. (1997). Application of chromosome 4q35-qter marker (pFR-1) for DNA rearrangement of facioscapulohumeral muscular dystrophy patients in Taiwan. J. Neurol. Sci. 149, 73-79.
19. Krom, Y.D., Dumonceaux, J., Mamchaoui, K., et al. (2012). Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD. Am. J. Pathol. 181, 1387-1401.
20. Krom, Y.D., Thijssen, P.E., Young, J.M., et al. (2013). Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet. 9, e1003415.
21. Lemmers, R.J., van der Vliet, P.J., Klooster, R., et al. (2010). A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653.
22. Liu, Q., Jones, T.I., Tang, V.W., et al. (2010). Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. J. Cell Sci. 123, 1116-1123.
23. Melnick, A., Ahmad, K.F., Arai, S., et al. (2000). In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20, 6550-6567.
24. Moore, G.D., Sinclair, D.A., and Grigliatti, T.A. (1983). Histone gene multiplicity and position effect variegation in Drosophila melanogaster. Genetics 105, 327-344.
25. Neguembor, M.V., and Gabellini, D. (2010). In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy. Epigenomics 2, 271-287.
26. Osborne, R.J., Welle, S., Venance, S.L., et al. (2007). Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68, 569-577.
27. Padberg, G.W., Brouwer, O.F., de Keizer, R.J., et al. (1995). On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve Suppl. 2, S73-S80.
28. Sakaki-Yumoto, M., Kobayashi, C., Sato, A., et al. (2006). The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development 133, 3005-3013.
29. Schotta, G., Lachner, M., Sarma, K., et al. (2004). A silencing pathway to induce H3-K9 andH4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18, 1251-1262.
30. Schotta, G., Sengupta, R., Kubicek, S., et al. (2008). A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 22, 2048-2061.
31. Sinclair, D., Mottus, R., and Grigliatti, T.A. (1983). Genes which suppress position-effect variegation in Drosophila melanogaster are clustered. Mol. Gen. Genet. 191, 326-333.
32. Snider, L., Asawachaicharn, A., Tyler, A.E., et al. (2009). RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet. 18, 2414-2430.
33. Snider, L., Geng, L.N., Lemmers, R.J., et al. (2010). Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181.
34. Sun, C.Y., van Koningsbruggen, S., Long, S.W., et al. (2011). Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein. J. Mol. Biol. 411, 397-416.
35. Tawil, R., Storvick, D., Feasby, T.E., et al. (1993). Extreme variability of expression in monozygotic twins with FSH muscular dystrophy. Neurology 43, 345-348.
36. Terranova, R., Sauer, S., Merkenschlager, M., et al. (2005). The reorganisation of constitutive heterochromatin in differentiating muscle requiresHDACactivity. Exp. Cell Res. 310, 344-356.
37. Tonini, M.M., Passos-Bueno, M.R., Cerqueira, A., et al. (2004). Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul. Disord. 14, 33-38.
38. Tsang, L.W., Hu, N., and Underhill, D.A. (2010). Comparative analyses of SUV420H1 isoforms and SUV420H2 reveal differences in their cellular localization and effects on myogenic differentiation. PLoS One 5, e14447.
39. Tupler, R., Barbierato, L., Memmi, M., et al. (1998). Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. J. Med. Genet. 35, 778-783.
40. Tupler, R., Perini, G., Pellegrino, M.A., et al. (1999). Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy. Proc. Natl Acad. Sci. USA 96, 12650-12654.
41. van der Maarel, S.M., Tawil, R., and Tapscott, S.J. (2011). Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol. Med. 17, 252-258.
42. van Deutekom, J.C., Wijmenga, C., van Tienhoven, E.A., et al. (1993). FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037-2042.
43. van Koningsbruggen, S., Dirks, R.W., Mommaas, A.M., et al. (2004). FRG1P is localised in the nucleolus, Cajal bodies, and speckles. J. Med. Genet. 41, e46.
44. van Koningsbruggen, S., Straasheijm, K.R., Sterrenburg, E., et al. (2007). FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma 116, 53-64.
45. Wijmenga, C., Hewitt, J.E., Sandkuijl, L.A., et al. (1992). Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 2, 26-30.
46. Winokur, S.T., Barrett, K., Martin, J.H., et al. (2003a). Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord. 13, 322-333.
47. Winokur, S.T., Chen, Y.W., Masny, P.S., et al. (2003b). Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 12, 2895-2907.
48. Wuebbles, R.D., Hanel, M.L., and Jones, P.L. (2009).FSHDregion gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis. Model. Mech. 2, 267-274.
49. Xynos, A., Corbella, P., Belmonte, N., et al. (2011). Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway. Stem Cells 28, 965-973.
50. Xynos, A., Neguembor, M.V., Caccia, R., et al. (2013). Facioscapulohumeral muscular dystrophy region gene 1 over-expression causes primary defects of myogenic stem cells. J. Cell Sci. 126(Pt 10), 2236-2245.
51. Yamashita, K., Sato, A., Asashima, M., et al. (2007). Mouse homolog of SALL1, a causative gene for Townes-Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains. Genes Cells 12, 171-182.
52. Zatz, M., Marie, S.K., Cerqueira, A., et al. (1998). The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am. J. Med. Genet. 77, 155-161.